ACT Project n.º 036AP/09 grant e Professor A. Collins for the FPG enzyme.
Au, W.W., Navasumrit, P. & Ruchirawat, M. (2004). Use of biomarkers to characterize functions of polymorphic DNA repair genotypes. International journal of hygiene and environmental health. 207 (4). p.pp. 301–313.
Blasiak, J., Kowalik, J., Małecka-Panas, E., Drzewoski, J. & Wojewódzka, M. (2000). DNA damage and repair in human lymphocytes exposed to three anticancer platinum drugs. Teratogenesis, Carcinogenesis, and Mutagenesis. 20 (3). p.pp. 119–131.
Branham, M.T., Nadin, S.B., Vargas-Roiq, L.M. & Ciocca, D.R. (2004). DNA damage induced by paclitaxel and DNA repair capability of peripheral blood lymphocytes as evaluated by the alkaline comet assay. Mutation Research. 560 (1). p.pp. 11 – 17.
Boiteux, S. & Radicella, J.P. (1999). Base excision repair of 8-hydroxyguanine protects DNA from endogenous oxidative stress. Biochimie. 81 (1-2). p.pp. 59–67.
Bouraoui, S., Brahem, A., Tabka, F., Mrizek, N., Saad, A. & Elghezal, H. (2011). Assessment of chromosomal aberrations, micronuclei and proliferation rate index in peripheral lymphocytes from Tunisian nurses handling cytotoxic drugs. Environmental Toxicology and Pharmacology. 31 (1). p.pp. 250–257.
Burgaz, S., Karahalil, B., Bayrak, P., Taşkin, L., Yavuzaslan, F., Bökesoy, I., Anzion, R.B., Bos, R.P. & Platin, N. (1999). Urinary cyclophosphamide excretion and micronuclei frequencies in peripheral lymphocytes and in exfoliated buccal epithelial cells of nurses handling antineoplastics. Mutation Research. 439 (1). p.pp. 97–104.
Buschini, A., Villarini, M., Feretti, D., Mussi, F., Dominici, L., Zerbini, I., Moretti, M., Ceretti, E., Bonfiglioli, R., Carrieri, M., Gelatti, U., Rossi, C., Monarca, S. & Poli, P. (2013). Multicentre study for the evaluation of mutagenic/carcinogenic risk in nurses exposed to antineoplastic drugs: assessment of DNA damage. Occupational and Environmental Medicine. 70 (11). p.pp. 789–794.
Cavallo, D., Ursini, C.L., Rondinone, B. & Iavicoli, S. (2009). Evaluation of a suitable DNA damage biomarker for human biomonitoring of exposed workers. Environmental and Molecular Mutagenesis. 50 (9). p.pp. 781–790.
Cooke, M.S., Evans, M.D., Dizdaroglu, M. & Lunec, J. (2003). Oxidative DNA damage: mechanisms, mutation, and disease. FASEB journal: official publication of the Federation of American Societies for Experimental Biology. 17 (10). p.pp. 1195–1214.
Collins, A.R. (1999). Oxidative DNA damage, antioxidants, and cancer. BioEssays: news and reviews in molecular, cellular and developmental biology. 21 (3). p.pp. 238–246.
Collins, A.R. (2009). Investigating oxidative DNA damage and its repair using the comet assay. Mutation Research. 681 (1). p.pp. 24–32.
Connor, T.H. (2006). Hazardous anticancer drugs in health care: environmental exposure assessment. Annals of the New York Academy of Sciences. 1076. p.pp. 615–623.
Digue, L., Orsière, T., De Méo, M., Mattéi, M.G., Depetris, D., Duffaud, F., Favre, R. & Botta, A. (1999). Evaluation of the genotoxic activity of paclitaxel by the in vitro micronucleus test in combination with fluorescent in situ hybridization of a DNA centromeric probe and the alkaline single cell gel electrophoresis technique (comet assay) in human T-lymphocytes. Environmental and Molecular Mutagenesis. 34 (4). p.pp. 269–278.
Duthie, S.J., Narayanan, S., Brand, G.M., Pirie, L. & Grant, G. (2002). Impact of Folate Deficiency on DNA Stability. The Journal of Nutrition. 132 (8). p.p. 2444S–2449S.
Fucic, A., Jazbec, A., Mijic, A., Šešo-Šimic, đ & Tomek, R. (1998). Cytogenetic consequences after occupational exposure to antineoplastic drugs. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 416 (1-2). p.pp. 59–66.
Gulten, T., Evke, E., Ercan, I., Evrensel, T., Kurt, E. & Manavoglu, O. (2011). Lack of genotoxicity in medical oncology nurses handling antineoplastic drugs: effect of work environment and protective equipment. Work (Reading, Mass.). 39 (4). p.pp. 485–489.
Hu, Y.C. & Ahrendt, S.A. (2005). hOGG1 Ser326Cys polymorphism and G:C-to-T:A mutations: no evidence for a role in tobacco-related non small cell lung cancer. International Journal of Cancer. Journal International Du Cancer. 114 (3). p.pp. 387–393.
Jiao, X., Huang, J., Wu, S., Lv, M., Hu, Y., Jianfu, null, Su, X., Luo, C. & Ce, B. (2007). hOGG1 Ser326Cys polymorphism and susceptibility to gallbladder cancer in a Chinese population. International Journal of Cancer. Journal International Du Cancer. 121 (3). p.pp. 501–505.
Kohno, T., Shinmura, K., Tosaka, M., Tani, M., Kim, S.R., Sugimura, H., Nohmi, T., Kasai, H. & Yokota, J. (1998). Genetic polymorphisms and alternative splicing of the hOGG1 gene, that is involved in the repair of 8-hydroxyguanine in damaged DNA. Oncogene. 16 (25). p.pp. 3219–3225.
Kopjar, N. & Garaj-Vrhovac, V. (2001). Application of the alkaline comet assay in human biomonitoring for genotoxicity: a study on Croatian medical personnel handling antineoplastic drugs. Mutagenesis. 16(1).p.pp. 71-8.
Kopjar, N., Milas, I., Garaj-Vrhovac, V. & Gamulin, M. (2006). Alkaline comet assay study with breast cancer patients: evaluation of baseline and chemotherapy-induced DNA damage in non-target cells. Clinical and Experimental Medicine. 6 (4). p.pp. 177–190.
Kopjar, N., Garaj-Vrhovac, V., Kašuba, V., Rozgaj, R., Ramić, S., Pavlica, V. & Želježić, D. (2009). Assessment of genotoxic risks in Croatian health care workers occupationally exposed to cytotoxic drugs: A multi-biomarker approach. International Journal of Hygiene and Environmental Health. 212 (4). p.pp. 414–431.
Laffon, B., Teixeira, J.P., Silva, S., Loureiro, J., Torres, J., Pásaro, E., Méndez, J. & Mayan, O. (2005). Genotoxic effects in a population of nurses handling antineoplastic drugs, and relationship with genetic polymorphisms in DNA repair enzymes. American Journal of Industrial Medicine. 48 (2). p.pp. 128–136.
Macpherson, P., Barone, F., Maga, G., Mazzei, F., Karran, P. & Bignami, M. (2005). 8-Oxoguanine incorporation into DNA repeats in vitro and mismatch recognition by MutSα. Nucleic Acids Research. 33 (16). p.pp. 5094–5105.
Pilger, A. & Rüdiger, H.W. (2006). 8-Hydroxy-2′-deoxyguanosine as a marker of oxidative DNA damage related to occupational and environmental exposures. International Archives of Occupational and Environmental Health. 80 (1). p.pp. 1–15. Pinkerton, L.E., Hein, M.J. & Stayner, L.T. (2004). Mortality among a cohort of garment workers exposed to formaldehyde: an update. Occupational and Environmental Medicine. 61 (3). p.pp. 193–200.
Sessink, P.J. & Bos, R.P. (1999). Drugs hazardous to healthcare workers. Evaluation of methods for monitoring occupational exposure to cytostatic drugs. Drug safety: an international journal of medical toxicology and drug experience. 20 (4). p.pp. 347–359.
Singh, N. & Lai, H. (2009). Methods for freezing blood samples at -80oC for DNA damage analysis in human leukocytes. In: The Comet Assay in Toxicology. Chapter 5. [Online]. Royal Society of Chemistry, pp. 120 – 128. Available from: www.rsc.org.
Singh, N.P., McCoy, M.T., Tice, R.R. & Schneider, E.L. (1988). A simple technique for quantitation of low levels of DNA damage in individual cells. Experimental Cell Research. 175 (1). p.pp. 184–191.
Ursini, C.L., Cavallo, D., Colombi, A., Giglio, M., Marinaccio, A. & Iavicoli, S. (2006). Evaluation of early DNA damage in healthcare workers handling antineoplastic drugs. International Archives of Occupational and Environmental Health. 80 (2). p.pp. 134–140.
Villarini, M., Dominici, L., Piccinini, R., Fatigoni, C., Ambrogi, M., Curti, G., Morucci, P., Muzi, G., Monarca, S. & Moretti, M. (2011). Assessment of primary, oxidative and excision repaired DNA damage in hospital personnel handling antineoplastic drugs. Mutagenesis. 26 (3). p.pp. 359–369.